Sun Pharma to buy Organon for $11.75B in major portfolio expansion
Indian drug giant Sun Pharma has lined up an $11.75 billion acquisition of Organon, a women’s health and biosimilar maker spun out of Merck in 2021. The all-cash deal came in at $14 per share ...
ORIGINAL SOURCE →via Endpoint News
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · IN
- [CONFLICT] India news: Delhi to get respite, heat wave persists in other parts
- [CONFLICT] India turns to Russian missiles to counter China-backed Pakistan
- [FINANCE] Global Dust & Emission Control Chemicals for Ore Handling Market Outlook (2026-2036): Growth Led by India, Indonesia & Chile with Ecolab and Solenis - Morningstar
- [HEALTH] India–New Zealand FTA: what's cheaper, what's protected, who benefits
- [CONFLICT] JSW Motors has a plan before India car debut
- [CONFLICT] Indian VC firm Capital-A raises $17m for deeptech fund